Evenity (romosozumab)

pCPA File Number: 21668

Negotiation Status:

Concluded with an LOI

Indication(s):

Osteoporosis

Sponsor/Manufacturer:

Amgen Canada Inc.

CDA-AMC Project Number:

SR0676-000

pCPA Engagement Letter Issued:

2022-03-31

Negotiation Process Concluded:

2023-06-28